Galapagos NV
GLPG
#4563
Rank
C$2.91 B
Marketcap
C$43.64
Share price
-0.57%
Change (1 day)
15.49%
Change (1 year)

Galapagos NV (GLPG) - Cash on Hand

Cash on Hand as of September 2025 : C$4.94 Billion

According to Galapagos NV's latest financial reports the company has C$4.94 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galapagos NV - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$4.65 B-13.83%
2023-12-31C$5.40 B-9.34%
2022-12-31C$5.95 B-12.21%
2021-12-31C$6.78 B-16.14%
2020-12-31C$8.09 B-4.29%
2019-12-31C$8.45 B320.47%
2018-12-31C$2.01 B15.83%
2017-12-31C$1.73 B26.23%
2016-12-31C$1.37 B166.52%
2015-12-31C$0.51 B94.83%
2014-12-31C$0.26 B30.43%
2013-12-31C$0.20 B63.16%
2012-12-31C$0.12 B189.49%
2011-12-31C$43 M-19.93%
2010-12-31C$53.71 M-24.82%
2009-12-31C$71.44 M53.86%
2008-12-31C$46.43 M-35.33%
2007-12-31C$71.8 M-9.28%
2006-12-31C$79.14 M143%
2005-12-31C$32.57 M94.58%
2004-12-31C$16.73 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
AstraZeneca
AZN
C$11.30 B 128.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
C$25.64 B 418.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$14.43 B 191.99%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
C$7.83 B 58.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
C$0.10 B-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.68 B 116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.04 B-38.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$6.13 B 24.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$25.16 B 408.83%๐Ÿ‡บ๐Ÿ‡ธ USA